Goldman Sachs Group set a €29.60 ($34.42) price target on Evonik Industries (FRA:EVK) in a research note published on Monday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
Other equities research analysts also recently issued research reports about the company. JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on Evonik Industries and gave the stock a neutral rating in a research report on Tuesday, November 5th. HSBC set a €25.00 ($29.07) price objective on Evonik Industries and gave the stock a neutral rating in a research report on Wednesday, September 18th. Sanford C. Bernstein set a €30.00 ($34.88) price objective on Evonik Industries and gave the stock a buy rating in a research report on Monday. Kepler Capital Markets set a €23.00 ($26.74) price objective on Evonik Industries and gave the stock a sell rating in a research report on Tuesday, November 5th. Finally, Barclays set a €24.00 ($27.91) price target on Evonik Industries and gave the company a neutral rating in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the stock. Evonik Industries currently has an average rating of Hold and an average target price of €28.19 ($32.78).
Shares of EVK stock traded down €0.24 ($0.28) on Monday, reaching €25.83 ($30.03). The company’s stock had a trading volume of 1,129,394 shares. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34). The stock’s 50 day simple moving average is €23.66 and its 200-day simple moving average is €24.29.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Recommended Story: Fundamental Analysis – How It Helps Investors
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.